GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (TSXV:COV) » Definitions » Cash, Cash Equivalents, Marketable Securities

Covalon Technologies (TSXV:COV) Cash, Cash Equivalents, Marketable Securities : C$9.41 Mil (As of Jun. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Covalon Technologies Cash, Cash Equivalents, Marketable Securities?

Covalon Technologies's quarterly cash, cash equivalents, marketable securities declined from Dec. 2023 (C$8.29 Mil) to Mar. 2024 (C$7.26 Mil) but then increased from Mar. 2024 (C$7.26 Mil) to Jun. 2024 (C$9.41 Mil).

Covalon Technologies's annual cash, cash equivalents, marketable securities declined from Sep. 2021 (C$22.95 Mil) to Sep. 2022 (C$14.06 Mil) and declined from Sep. 2022 (C$14.06 Mil) to Sep. 2023 (C$8.80 Mil).


Covalon Technologies Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Covalon Technologies's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covalon Technologies Cash, Cash Equivalents, Marketable Securities Chart

Covalon Technologies Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.58 3.51 22.95 14.06 8.80

Covalon Technologies Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.19 8.80 8.29 7.26 9.41

Covalon Technologies Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Covalon Technologies  (TSXV:COV) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Covalon Technologies Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Covalon Technologies's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Covalon Technologies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (TSXV:COV) » Definitions » Cash, Cash Equivalents, Marketable Securities
Traded in Other Exchanges
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.
Executives
Amir Boloor Director
Valerio Ditizio Director or Senior Officer of 10% Security Holder, Senior Officer

Covalon Technologies Headlines

No Headlines